Lilly

The AI-powered platform enhancements are aimed at supporting employee requests, coaching and career guidance, and workforce planning.

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross domestic product. McKinsey & Co. follows suit, noting AI could generate 30% efficiency gains and cost savings in the pharmaceutical sector and trigger financial gains of up to $110 billion annually.

A little over a year ago, a Renton man was told there was only one thing left to decide. Did he want to die at home, or in the hospital? He's still living.

Lily AI CEO Purva Gupta and A.L.C.'s Hilary Peterson to highlight insights and opportunities to capture consumer spend and loyalty Shoptalk 2025 Techtalk with Lily AI and A.L.C.

In an exclusive interview, Lily AI's Purva Gupta shares insights into AI with the latest fashion-focused research highlighting generational and technology consumer behaviors.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO says can "understand the concept of time and how you change, from cradle to grave.

Suki is establishing itself as a darling of some of the largest health care companies in the country. On March 3, Rush—the Chicago-based academic medical center—announced that it will deploy Suki's technology across its entire enterprise,

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases offering training for it.